Warsaw, Ind-based Zimmer Biomet’s recent acquisition of Colorado-based Ortho Transmission LLC also includes its skeletal implant technology for amputees.
This technology complements Zimmer Biomet’s ongoing collaboration with the US Department of Defense for the development of a transcutaneous system for anchoring external prosthetic limbs, in order to restore the mobility of amputee patients, according to a media release from Zimmer Biomet.
“Transcutaneous osseous integrated technology represents a fundamental innovation in limb replacement, and Zimmer Biomet is proud to leverage our musculoskeletal expertise to significantly improve the quality of life of amputee patients living in the United States and around the world,” says Todd Davis, vice president & general manager of the global knee business, in the release.
“Our leading research and development capabilities, combined with our proprietary Trabecular Metal™ material to support bone ingrowth and vascularization, represents the ideal platform to accelerate the commercialization of this implant. This acquisition also perfectly aligns with our broad-based focus on clinically relevant innovations,” he adds.
Zimmer Biomet aims to leverage designs acquired from Ortho Transmission in order to offer this technology to patients, beginning with a clinical trial, per the release.
For more information, visit Zimmer Biomet.
[Source(s): Zimmer Biomet, PR Newswire]
